Skip to content

Prevalence of nicotine product use among people with mental health conditions compared to the general population

Prevalence of nicotine product use among people with mental health conditions compared to the general population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039928
Enrollment
200
Registered
2026-05-22
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nicotine use

Interventions

Group 1: Patients with psychiatric disorders who are receiving inpatient or outpatient care at Department of Psychiatry and Psychotherapy, LVR University Hospital Essen are asked to complete the “Smok

Sponsors

LVR-Klinik für Psychiatrie und Psychotherapie Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Adult patients receiving outpatient or inpatient treatment at the LVR-Klinikum Essen. -Diagnosed (ICD-10) mental disorders, particularly opioid dependence, alcohol dependence, cannabis dependence, depressive disorders, schizophrenia-spectrum psychoses, and anxiety disorders.

Exclusion criteria

Exclusion criteria: -Insufficient understanding of the German language to comprehend the patient information and ensure that the interview can be conducted adequately. -Severe cognitive impairments, e.g., Korsakoff syndrome, progression of dementia -Acute psychiatric illness (e.g., active psychotic illness) of such intensity that adequate cooperation in the examination is not possible. -The informed consent form was not signed.

Design outcomes

Primary

MeasureTime frame
Outcome: Reduction in nicotine consumption among psychiatric patients comparable to that in the general population When: Upon new admission (inpatient or outpatient) to the Department of Psychiatry and Psychotherapy, LVR University Hospital Essen How: “Smoke-Free Hospital Survey” questionnaire

Secondary

MeasureTime frame
Differences in nicotine use in terms of quantity and mode of use among individuals with psychiatric disorders compared to the general population. Identification of identifiable reasons for the differences in prevalence of use

Countries

Germany

Contacts

Public ContactNorbert Scherbaum

LVR-Klinik für Psychiatrie und Psychotherapie Essen

Norbert.Scherbaum@lvr.de+49 201 7227 200

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026